Safranal's therapeutic effects in rat models of polycystic ovary syndrome-Reference-Cited by-同舟云学术

Safranal's therapeutic effects in rat models of polycystic ovary syndrome

Published:2023-11-15 Issue: Volume: Page:
ISSN:1981-528X
Container-title:Revista Brasileira de Farmacognosia
language:en
Short-container-title:Rev. Bras. Farmacogn.

Author:

Cellat Mustafa^ORCID,Kuzu Müslüm^ORCID,Güvenç Mehmet^ORCID,Yüksel Murat^ORCID,Kanat Özgür^ORCID,Akaydın Bozkurt Yeşim^ORCID,Etyemez Muhammed^ORCID,Karaca Fikret^ORCID

Funder

Mustafa Kemal Üniversitesi

Publisher

Springer Science and Business Media LLC

Subject

General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s43450-023-00484-6.pdf

Reference47 articles.

1. Abasian Z, Rostamzadeh A, Mohammadi M, Hosseini M, Rafieian-kopaei M (2018) A review on role of medicinal plants in polycystic ovarian syndrome: pathophysiology, neuroendocrine signaling, therapeutic status and future prospects. Middle East Fertil Soc J 23:255–262. https://doi.org/10.1016/J.MEFS.2018.04.005

2. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126. https://doi.org/10.1016/S0076-6879(84)05016-3

3. Alayunt ÖN, Aksoy L, Karafakioğlu YS, Sevimli S (2019) Assessment of anti-inflammatory and antioxidant properties of safranal on CCl4-induced oxidative stress and inflammation in rats. An Acad Bras Cienc 91:e20181235. https://doi.org/10.1590/0001-3765201920181235

4. Ali SE, El Badawy SA, Elmosalamy SH, Emam SR, Azouz AA, Galal MK, Abd-Elsalam RM, Issa MY, Hassan BB (2021) Novel promising reproductive and metabolic effects of Cicer arietinum L. extract on letrozole induced polycystic ovary syndrome in rat model. J Ethnopharmacol 278:114318. https://doi.org/10.1016/J.JEP.2021.114318

5. Badawy A, Elnashar A (2011) Treatment options for polycystic ovary syndrome. Int J Womens Health 3:25–35. https://doi.org/10.2147/IJWH.S11304